SLC11A2 and hepatocellular carcinoma: By analyzing the relationship between FTH1, FTL, HMOX1, SLC11A2, SLC39A14 and TFRCDACH1 and the clinical pathological stages of HCC, we found that the expression of these genes increased gradually in Stage I, Stage II and Stage III.